共 123 条
[1]
Baumgart DC(2012)Crohn’s disease Lancet 380 1590-605
[2]
Sandborn WJ(2009)Loss of response and requirement of infliximab dose intensification in Crohn’s disease: a review Am J Gastroenterol 104 760-7
[3]
Gisbert JP(2011)Loss of response and need for adalimumab dose intensification in Crohn’s disease: a systematic review Am J Gastroenterol 106 674-84
[4]
Panes J(2013)Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation J Allergy Clin Immunol 131 825-30
[5]
Billioud V(1998)Course of Crohn’s disease after allogeneic marrow transplantation Gastroenterology 114 433-40
[6]
Sandborn WJ(2005)Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients J Exp Med 201 805-16
[7]
Peyrin-Biroulet L(2005)Autologous hematopoietic stem cell transplantation in patients with refractory Crohn’s disease Gastroenterology 128 552-63
[8]
Engelhardt KR(2010)Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up Blood 116 6123-32
[9]
Shah N(2012)Remission of refractory Crohn’s disease by high-dose cyclophosphamide and autologous peripheral blood stem cell transplantation Aliment Pharmacol Ther 36 725-35
[10]
Faizura-Yeop I(2003)Complete remission of Crohn’s disease after high-dose cyclophosphamide and autologous stem cell transplantation Bone Marrow Transplant 32 337-40